← Open Payments lookup

WILLIAM CRAIG: Open Payments

NPI 1396265427 · DERIDDER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$979 in 42 payments from 10 companies in 2025. Trend: 2023 $330 · 2024 $662 · 2025 $979

Food & beverage: $862Education: $117
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.14$319
Teva Pharmaceuticals USA, Inc.8$249
Alkermes, Inc.4$86
Janssen Pharmaceuticals, Inc3$71
Vanda Pharmaceuticals Inc.3$62
E.R. Squibb & Sons, L.L.C.3$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
ABBVIE INC.2$39
Axsome Therapeutics, Inc.2$35
Otsuka America Pharmaceutical, Inc.1$23

Products named: Qelbree, ARISTADA, UZEDY, SPRAVATO, AUSTEDO XR, COBENFY, CAPLYTA, VRAYLAR.

Industry payments across LA — which companies pay providers there.